Infinity Pharmaceuticals, Inc.
INFIDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001113148
Infinity Pharmaceuticals, Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Sep 12, 2023; 45 institutions reported holding it in 13F filings for Q2 2023, worth $4.23M in total; no superinvestor held it.
Holders of 5% or more of INFI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Infinity Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Infinity Pharmaceuticals, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
15 Schedule 13D and 13G filings on Infinity Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2023 | Polar Capital Holdings Plc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jul 8, 20224:56 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Feb 14, 2022 | Polar Capital Holdings Plc | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Biotechnology Value Fund L P | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Feb 4, 20224:12 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Jan 18, 2022 | Integrated Core Strategies (US) LLC | 13G/AOld format | – | – | – | SEC |
| Jun 17, 2021 | Integrated Core Strategies (US) LLC | 13GOld format | – | New | – | SEC |
| Feb 19, 2021 | Biotechnology Value Fund L P | 13GOld format | – | – | – | SEC |
| Feb 16, 2021 | Biotechnology Value Fund L P | 13D/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Opaleye Management Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 26, 2021 | EcoR1 Capital, LLC | 13GOld format | – | New | – | SEC |
| Jan 26, 2021 | Biotechnology Value Fund L P | 13D/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Infinity Pharmaceuticals, Inc. shares.
No Form 144 notices for Infinity Pharmaceuticals, Inc. are on file.